ABOUT US
JPS is a clinical stage therapeutics company focused on developing a 7-day treatment of periprosthetic joint infection using local antibiotic irrigation.
FOUNDERS
Brian C. de Beaubien, MD
CLINICAL STUDY
The X7 Spacer System is a temporary implant with local antibiotic irrigation for a 7-day two-stage exchange arthroplasty.
This product is not approved for sale in the U.S.
We are recruiting study sites for a U.S. Phase 3 clinical study of chronic PJI in the knee and hip.
Phase 2 study information can be found at: https://clinicaltrials.gov/ct2/show/NCT03721328.